MEDIKAMENTENSPENDER
European patent · EP1962932 · In force
Register entry
- Publication number
- EP1962932
- Application number
- EP06820486
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Dec 11, 2006
- Published
- Sep 3, 2008
- Granted
- Sep 8, 2021
- Protection ends at the latest
- Dec 10, 2026
- Next annual fee due
- Dec 31, 2026
- IPC classes
- A61M 15/00 (2006.01)
- Priority
- GB 0525238 12.12.2005GB 0623402 23.11.2006
- PCT application
- PCT/GB2006/004623 11.12.2006
- PCT publication
- WO2007/068900 21.06.2007
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jan 1, 2026
Change
Published in Swissreg on 01.01.2026
- Dec 23, 2025
Holder’s address changed
- Owner
- Glaxo Group Limited, 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom → Glaxo Group Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom
Published in Swissreg on 23.12.2025
- Jan 1, 2025
Change
Published in Swissreg on 01.01.2025
- Jan 1, 2024
Change
Published in Swissreg on 01.01.2024
- Jan 1, 2023
Change
Published in Swissreg on 01.01.2023
- Jul 20, 2022
Change
Published in Swissreg on 20.07.2022
- Nov 17, 2021
Agent entered
- Representative
- AWA Switzerland Ltd., Case Postale 2243, 2800 Delémont 2
Published in Swissreg on 17.11.2021
- Sep 8, 2021
Granted
Published in Swissreg on 08.09.2021
Parties
Inventor
Ware Hertfordshire SG12 0DP, GB
Ware Hertfordshire SG12 0DP, GB
Ware Hertfordshire SG12 0DP, GB
Ware Hertfordshire SG12 0DP, GB
Ware Hertfordshire SG12 0DP, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.